Rivaroxaban potentially inferior to vitamin K antagonists for treatment of thrombotic antiphospholipid antibody syndrome
1. In this randomized study comparing the efficacy of rivaroxaban with warfarin, dose-adjusted rivaroxaban treatment resulted in near doubling of ...